Items tagged with HIV coinfection
HIV and tuberculosis are one disease in Southern Africa (post)
“We must ensure that the worlds of HIV and TB focus on individual human beings instead of individual diseases”
Novel TB regimen could reduce treatment duration (post)
A novel TB drug regimen could treat drug-sensitive and some forms of drug-resistant TB far more quickly than current standard TB therapy, according to findings from a phase IIb trial were presented today at the 20th International AIDS Conference (AIDS 2104) in Melbourne, Australia.
Deaths and infections from HIV, tuberculosis, and malaria plummet globally (post)
New HIV infections dropped by almost one-third from the epidemic peak; TB deaths declined by 3.7% between 2000 and 2013; child deaths from malaria in sub-Saharan Africa have dropped 31.5% in the past decade. Despite major progress, the quality of programs to treat HIV varies widely.
AIDS 2014: HIV and tuberculosis co-infection — no one left behind (post)
MELBOURNE, AUSTRALIA – “Why do we still have 320,000 deaths from TB in people living with HIV each year?”
Call to step up the pace of TB-HIV collaborative activities (post)
“We must focus upon individual human beings rather than on individual diseases of TB and HIV. A person centric approach is bound to work together than a disease centric approach,” said Mark Dybul, Executive Director, Global Fund to fight AIDS, Tuberculosis and Malaria at a high level WHO consultation, held in conjunction with 20th International AIDS Conference (AIDS 2014), to discuss policies to catalyze the response for elimination of TB deaths among people living with HIV (PLHIV).
Study in South African township shows HIV-negative individuals often source of new TB cases in patients with HIV (post)
HIV-negative individuals are an important source of new tuberculosis (TB) cases in HIV-positive patients, according to a study conducted in a South African township published in the online edition of the Journal of Infectious Diseases.
High level international WHO consultation: Eliminating TB deaths: Time to step up the HIV response (post)
Sunday 20 July 2014 | Promenade Room 3, Crowne Promenade, 8 Whiteman St, Melbourne, Victoria, Australia
Mortality risk in CAMELIA TB patients starting antiretrovirals (post)
Tuberculosis and other HIV diseases accounted for three quarters of the deaths in the first 26 weeks of the CAMELIA trial of early versus delayed antiretroviral therapy (ART) for people being treated for TB. An array of factors explained a higher risk of death.
Global research reaches for consensus on HIV treatment response (post)
THE body’s natural reaction to infection is responsible for potentially fatal side-effects of antiretroviral therapy in patients with HIV, according to research.
Acquired rifampicin resistance more likely in HIV-coinfected patients (post)
Patients with HIV and tuberculosis were more likely to develop acquired rifampicin resistance when treated with a thrice-weekly tuberculosis treatment compared with patients not coinfected with HIV, according to researchers from the National Institute for Research in Tuberculosis in India.
Page 7 of 52 · Total posts: 0
←First 6 7 8 Last→